期刊文献+

老年骨质疏松患者唑来膦酸急性期反应与性别和双膦酸盐类药物使用史的关系 被引量:7

Relation among acute phase reaction of zoledronic acid,sexuality and previous use of bisphosphonates in elderly osteoporotic patients
下载PDF
导出
摘要 目的调查分析老年骨质疏松患者唑来膦酸急性期反应(APR)与性别和双膦酸盐类(BPs药物使用史的关系。方法选择2016年1月至2018年12月来浙江省人民医院望江山院区老年医学科住院治疗的115例老年骨质疏松患者。在静脉滴注唑来膦酸(5 mg)后,记录患者在72 h内发热、肌痛、胃肠道症状、流感样症状、神经系统症状等APR的发生情况,并分析APR与性别和BPs药物使用史的关系。结果不同性别老年骨质疏松患者间常见APR发生率差异均无统计学意义(均P>0.05)。而有BPs使用史的老年骨质疏松患者发热、肌痛、胃肠道症状、流感样症状、神经系统症状等APR发生率明显低于无BPs使用史的患者[24.4%(11/45)比55.7%(39/70)、22.2%(10/45)比41.4%(29/70)、15.6%(7/45)比34.3%(24/70)、13.3%(6/45)比31.4%(22/70)、11.1%(5/45)比32.9%(23/70)、13.3%(6/45)比34.3%(24/70)],差异均有统计学意义(均P<0.05)。发热患者伴随其他APR(2.04±1.68)个,明显高于不发热的患者的(0.75±0.10)个,差异有统计学意义(P<0.01)。结论老年骨质疏松患者在接受唑来膦酸治疗后容易出现发热等APR,而有BPs使用史的患者APR较少。 Objective To investigate the relation among acute phase reaction(APR)of zoledronic acid,sexuality and previous use of bisphosphonates in elderly osteoporotic patients.Methods From January 2016 to December 2018,115 elderly patients with osteoporosis were hospitalized in Wangjiangshan Branch,Zhejiang Provincial People’s Hospital.All patients had intravenous infusion of zoledronic acid(5 mg).Occurrence of APR such as fever,myalgia,gastrointestinal symptoms,influenza-like symptoms and neurological symptoms were observed.Relations among APR,sexuality and previous use of bisphosphonates were analyzed.Results There was no significant difference in zoledronic acid-induced APR between males and females(P>0.05).Incidences of fever,myalgia,gastrointestinal symptoms,influenza-like symptoms and neurological symptoms in patients who had previous use of bisphosphonates were significantly lower than those in patients without bisphosphonates use history[24.4%(11/45)vs 55.7%(39/70),22.2%(10/45)vs 41.4%(29/70),15.6%(7/45)vs 34.3%(24/70),13.3%(6/45)vs 31.4%(22/70),11.1%(5/45)vs 32.9%(23/70),13.3%(6/45)vs 34.3%(24/70)](all P<0.05).Numbers of APR accompanied symptoms in fever patients were significantly more than those in non-fever patients[(2.04±1.68)vs(0.75±0.10)](P<0.01).Conclusions There is a high incidence of APR in elderly osteoporotic patients treated with zoledronic acid.Patients with previous use history of bisphosphonates may have less adverse reaction.
作者 沈佶 吴惠英 边平达 陈锦平 Shen Ji;Wu Huiying;Bian Pingda;Chen Jinping(Department of Geriatrics,Wangjiangshan Branch of Zhejiang Provincial People's Hospital,People's Hospital of Hangzhou Medical College,Hangzhou 310024,China)
出处 《中国医药》 2020年第2期288-291,共4页 China Medicine
基金 浙江省医药卫生平台重点资助项目(2016ZDA002)。
关键词 骨质疏松 唑来膦酸 急性期反应 发热 Osteoporosis Zoledronic acid Acute phase reaction Fever
  • 相关文献

参考文献12

二级参考文献97

  • 1刘瑶,刘治军,傅得兴.新一代二膦酸盐类药物唑来膦酸的药理及临床[J].中国新药杂志,2004,13(11):1058-1060. 被引量:11
  • 2蒋晔,张晓青,徐智儒.抗恶性高钙血症药物——唑来膦酸[J].中国药学杂志,2005,40(14):1117-1118. 被引量:2
  • 3彭六保,崔巍.唑来膦酸的临床应用研究进展[J].中国新药与临床杂志,2007,26(3):237-240. 被引量:36
  • 4Sabry NA,Habib EE.Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy andsafety comparative study.Med Oncol,2011,28 (2):584-590. 被引量:1
  • 5Alegre A,Gironella M,Bailén A,et al.Zoledronic acid in the management of bone disease as a consequence of multiple myeloma:a review[J].Eur J Haematol,2014,92(3):181-188. 被引量:1
  • 6Reid IR,Gamble GD,Mesenbrink P,et al.Characterization of and risk factors for the acute-phase response after zoledronic acid[J].J Clin Endocrinol M etab,2010,95(9):4380-4387. 被引量:1
  • 7Lowe NM,Mitra SR,Foster PC,et al.Vitamin D status and markers of bone turnover in Caucasian and South Asian postmenopausal women living in the UK[J].Br J Nutr,2010,103(12):1706-1710. 被引量:1
  • 8Evdokiou A,Labrinidis A.Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis[J].Bone,2003,33(2):216-228. 被引量:1
  • 9Dicuonzo G,Vincenzi B,Santini D,et al.Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6[J].J Interferon Cytokine Res,2003,23(11):649-654. 被引量:1
  • 10Lewiecki EM.Intravenous zoledronic acid for the treatment of osteoporosis:the evidence of its therapeutic effect[J].Core Evid,2010,4(4):13-23. 被引量:1

共引文献1475

同被引文献75

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部